Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0DD9F
|
|||
| Former ID |
DIB000765
|
|||
| Drug Name |
HumaSPECT
|
|||
| Synonyms |
Votumumab; Votumumab-Y90; Onco-SPECT-Y90; 88BV59-LiLo.Y-90
Click to Show/Hide
|
|||
| Indication | Prostate cancer [ICD-11: 2C82.0; ICD-10: C61; ICD-9: 185] | Phase 3 | [1] | |
| Company |
Akzo Nobel NV
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Radioimmunoscintigraphy of recurrent, metastatic, or occult colorectal cancer with technetium Tc 99m 88BV59H21-2V67-66 (HumaSPECT-Tc), a totally human monoclonal antibody. Patient management benefit from a phase III multicenter study. Dis Colon Rectum. 1998 Aug;41(8):953-62. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.